🇮🇱 Israel Country × Condition
type 1 diabetes Clinical Trials in Israel
Active clinical trials for type 1 diabetes with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇮🇱 Israel
Active Trials in Israel (2)
NCT07360080
Recruiting
Long-Term Outcomes of Teplizumab in Routine Clinical Care
Enrollment
1,000 pts
Country
🇮🇱 Israel
Sanofi
View Trial → NCT06966427
Recruiting
Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections
Enrollment
45 pts
Country
🇮🇱 Israel
Rabin Medical Center
View Trial → Frequently Asked Questions
How many type 1 diabetes clinical trials are active in Israel?
There are currently 2 active clinical trials for type 1 diabetes with sites in Israel, of which 2 are actively recruiting patients.
How can I join a type 1 diabetes clinical trial in Israel?
To join a type 1 diabetes clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are type 1 diabetes trials in Israel?
Active type 1 diabetes trials in Israel span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology